Papillary thyroid carcinoma coexisting with ALK-negative anaplastic large-cell lymphoma: An exceptional clinical case report

Papillary thyroid carcinoma coexisting with ALK-negative anaplastic large-cell lymphoma: An exceptional clinical case report

Bibliographic Details
Main Authors:	Zhenzhen Guo, Haider Ali, Shixiong Wang, Jinmao Li
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Asian Journal of Surgery
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958423019887

Similar Items

Pathobiology of ALK-negative anaplastic large cell lymphoma
by: Stefano A. Pileri, et al.
Published: (2011-06-01)

Educational Case: ALK-Negative Anaplastic Large Cell Lymphoma
by: Akira Satou MD, PhD, et al.
Published: (2020-01-01)

Granulomatous Inflammation in a Patient with ALK-Negative Anaplastic Large Cell Lymphoma
by: Özlem Kandemir Alibakan, et al.
Published: (2022-02-01)

An Exploration into the Origins and Pathogenesis of Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase (ALK)-Positive
by: Suzanne D. Turner
Published: (2017-10-01)

ALK-negative anaplastic large cell lymphoma mimicking a soft tissue sarcoma
by: Rachel Hudacko, et al.
Published: (2011-01-01)

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma
by: Serena Stadler, et al.
Published: (2018-04-01)

Holistic View of ALK TKI Resistance in ALK-Positive Anaplastic Large Cell Lymphoma
by: Yuan Wang, et al.
Published: (2022-02-01)

ALK signaling and target therapy in anaplastic large cell lymphoma
by: Fabrizio eTabbo, et al.
Published: (2012-05-01)

Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by Hashimoto's thyroiditis
by: Maria Trovato, et al.

From Pathology to Precision Medicine in Anaplastic Large Cell Lymphoma Expressing Anaplastic Lymphoma Kinase (ALK+ ALCL)
by: Michael T. Werner, et al.
Published: (2017-10-01)

ALK-Negative Anaplastic Large Cell Lymphoma: Current Concepts and Molecular Pathogenesis of a Heterogeneous Group of Large T-Cell Lymphomas
by: Sergio Pina-Oviedo, et al.
Published: (2021-09-01)

MOLECULAR BIOLOGICAL CHARACTERISTICS OF ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA
by: E. V. Chernyshova, et al.
Published: (2017-01-01)

Metallic implant-associated lymphoma: ALK-negative anaplastic large cell lymphoma associated with total knee replacement arthroplasty
by: Jai-Hyang Go
Published: (2023-01-01)

Primary CNS ALK-negative anaplastic large cell lymphoma: A case report and review of the literature
by: Amy L. Brady, DO, et al.
Published: (2024-01-01)

Coexistence of Hashimoto's thyroiditis and papillary thyroidal carcinoma with papillary carcinoma of thyreoglossal duct
by: Čizmić Milica, et al.
Published: (2007-01-01)

Anaplastic thyroid carcinoma diagnosed after treatment of lenvatinib for papillary thyroid carcinoma
by: Haruhiko Yamazaki, et al.
Published: (2019-10-01)

A Case of ALK-Positive Anaplastic Large Cell Lymphoma of the Male Breast
by: Wang X, et al.
Published: (2023-11-01)

Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma
by: Giulia Arosio, et al.
Published: (2021-09-01)

Regulation of CD45 phosphatase by oncogenic ALK in anaplastic large cell lymphoma
by: Giulia Mura, et al.
Published: (2023-01-01)

ALK Positive Anaplastic Large Cell Lymphoma Presenting as Extensive Bone Involvement
by: Smeeta Gajendra, et al.
Published: (2015-01-01)

NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma
by: Moinul Haque, et al.
Published: (2019-08-01)

NPM-ALK-reactive T-cell responses in children and adolescents with NPM-ALK positive anaplastic large cell lymphoma
by: Vijay Kumar Singh, et al.
Published: (2019-09-01)

Coexistence of papillary thyroid carcinoma in secondary hyperparathyroidism
by: Junhao Ma, et al.
Published: (2021-09-01)

Acquired L1196M ALK mutation in anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma during alectinib administration
by: Kazuhiro Noguchi, et al.
Published: (2023-02-01)

Anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma (ALCL) of breast in a patient without a breast implant
by: Vishwanath Sathyanarayanan, et al.
Published: (2014-11-01)

Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma.
by: Pulford, K, et al.
Published: (2000)

Role of ALK Inhibitors in Anaplastic Large Cell Lymphoma—Experience from an Indian Center
by: Muthiah Vaikundaraja Indhuja, et al.

Alk (−) anaplastic large cell lymphoma diagnosed by tongue root biopsy: case report
by: F. Yilmaz, et al.
Published: (2020-10-01)

ALK+ Anaplastic Large Cell Lymphoma (ALCL)-Derived Exosomes Carry ALK Signaling Proteins and Interact with Tumor Microenvironment
by: Dimitrios Chioureas, et al.
Published: (2022-06-01)

Composite lymphoma with coexistence of diffuse large B-cell lymphoma and anaplastic large cell lymphoma: Diagnostic pitfalls
by: Meyyappa Devan Rajagopal, et al.
Published: (2017-01-01)

Anaplastic lymphoma kinase (ALK)-rearranged pulmonary pleomorphic carcinoma successfully treated with crizotinib
by: Liping Lin, et al.
Published: (2018-08-01)

Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient with ALK‐positive anaplastic large‐cell lymphoma refractory to chemotherapy and brentuximab vedotin
by: Ritsuko Nakai, et al.
Published: (2019-12-01)

Coexistence of Medullary and Papillary Thyroid Carcinomas Detected Incidentally
by: Ensar Aydemir, et al.
Published: (2021-03-01)

Coexistence of primary thyroid diffuse large B cell lymphoma and papillary thyroid carcinoma in a patient with Hashimoto’s thyroiditis: a case report and literature review
by: Juncheng Li, et al.
Published: (2023-10-01)

Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas.
by: Leandro Cerchietti, et al.
Published: (2011-01-01)

Detection of NPM-ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma.
by: Waggott, W, et al.
Published: (1995)

Gene Expression Signature Associated with Clinical Outcome in ALK-Positive Anaplastic Large Cell Lymphoma
by: Camille Daugrois, et al.
Published: (2021-11-01)

ALK+ Anaplastic Large Cell Lymphoma of Null Cell Phenotype with Leukemic Transformation and Leukemoid Reaction
by: Shih-Sung Chuang, et al.
Published: (2019-11-01)

Anaplastic lymphoma kinase (ALK) gene alteration in signet ring cell carcinoma of the gastrointestinal tract
by: Olatunji B. Alese, et al.
Published: (2015-03-01)

Isolated Central Nervous System Involvement after Brentuximab Vedotin Treatment for HIV-Positive ALK-Negative Anaplastic Large Cell Lymphoma
by: Takuya Suyama, et al.
Published: (2024-01-01)